Genomic sequencing specialist Wuxi Nextcode Inc. has received a significant cash infusion to further develop what it is calling the "gold standard" for a genomics database. The Shanghai-based company closed on a $240 million series B funding round it started near the end of the first quarter. Previously, the company had raised about $30 million.